procaspase-activating compound 1 | |
---|---|
Trade Name | |
Orphan Indication | Glioma |
USA Market Approval | USA |
USA Designation Date | 2015-07-23 00:00:00 |
Sponsor | Vanquish Oncology, Inc.;2001 S. First Street, Suite 201;Champaign, Illinois, 61820 |
Related Access Program